Clinical trial
Study of Valproate in Young Patients Suffering From Epilepsy
NCT00385411 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00385411 |
|---|---|
| Title | Study of Valproate in Young Patients Suffering From Epilepsy |
| Official title | Therapeutic Follow-up Observational Study and Population Kinetics Ancillary Study of Valproate Microgranules (Micropakine® SR) in Patients Aged Between 6 Months and 15 Years Suffering From Epilepsy. |
| Acronym | VAPOP |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | valproate microgranules |
| Enrollment | 81 |
| Start date | Mar 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Oct 9, 2006 |
| Last update posted | Oct 6, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: